PBX1 appears to be a significant factor in chronic myeloid leukemia (CML) as it promotes tumor cell proliferation through its interaction with RNF6, a direct target of PBX1 [6,29]. This evidence concerns the gene RNF6 and chronic myelogenous leukemia, BCR-ABL1 positive.